Dana-Farber Cancer Institute

The addition of neoadjuvant and adjuvant pembrolizumab to standard of care significantly improved outcomes for certain patients with advanced head and neck squamous cell carcinoma, according to results of a randomized phase 3 study.

Most women with breast cancer who paused endocrine therapy to get pregnant did not restart treatment after having a child, according to results of a nearly 25-year retrospective study.

Joseph O. Jacobson, MD, MSc, teaches fellows that patients with cancer can suffer in three different ways.

More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or depression, according to study results.

Subcutaneous administration of trastuzumab and pertuzumab significantly shortened the time patients with stage I HER2-positive breast cancer spent getting treatment compared with IV delivery, according to results of a prospective study.

More than one-fourth of adolescents and young adults with cancer who wished to die at home did not attain this goal, according to research published in JAMA Network Open.

Cannabidiol may reduce scan-related anxiety among women with advanced breast cancer, according to results of randomized phase 2 study results.

SAN DIEGO — Lauren E. Merz, MD, MSc, can still feel both the relief and anger two parents expressed during her first year of medical school at University of Michigan.

SAN DIEGO — In this video, Marlise R. Luskin, MD, MSCE, highlights updates from two groups evaluating blinatumomab and ponatinib for the treatment of acute lymphoblastic leukemia.

Glucarpidase significantly improved kidney function for patients who developed acute kidney injury from high-dose methotrexate, according to results of a large, multicenter observational study.